ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

OCTP Oxford Cannabinoid Technologies Holdings Plc

0.115
0.00 (0.00%)
13 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Oxford Cannabinoid Technologies Holdings Plc LSE:OCTP London Ordinary Share GB00BMVMRB86 ORD GBP0.001
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.115 0.10 0.13 - 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Coml Physical, Biologcl Resh 0 -5.95M -0.0062 -0.18 1.1M
Oxford Cannabinoid Technologies Holdings Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker OCTP. The last closing price for Oxford Cannabinoid Techn... was 0.12p. Over the last year, Oxford Cannabinoid Techn... shares have traded in a share price range of 0.10p to 0.806p.

Oxford Cannabinoid Techn... currently has 960,415,644 shares in issue. The market capitalisation of Oxford Cannabinoid Techn... is £1.10 million. Oxford Cannabinoid Techn... has a price to earnings ratio (PE ratio) of -0.18.

Oxford Cannabinoid Techn... Share Discussion Threads

Showing 951 to 969 of 975 messages
Chat Pages: 39  38  37  36  35  34  33  32  31  30  29  28  Older
DateSubjectAuthorDiscuss
01/10/2024
05:53
it's gone now from the ISA. anyone any info whats the next step?
dan666
14/7/2024
19:35
I hope each trial fails miserably
turbotrader2
13/6/2024
10:05
Can someone explain what happens to my shares now ? thanks
fizzy2
05/6/2024
15:23
whose buying when his delists tomorrow
citys2874
05/6/2024
15:16
If there is shareholders, they should hold the bod accountable for instilling fear into shareholders with regards delisting.
jayrh
04/6/2024
23:11
Decided to hold - rumours on the horizon for a really positive update and new finance JV
Nice 27M buy

sep800
31/5/2024
23:22
Does anyone here have any faith for the future of this company once it delist ?
I am still on the side lines wether to sell my holding or hold. Never keen to sell at a loss at this level but at the same time can we trust the board that existing holders will be protected although technically share will be worth zero without able to trade.
Are we selling or holding ?
Comments welcome

sep800
21/5/2024
15:25
REVERSAL BOUNCE UP COMING IN HERE AND RTOP VERY NICE INDEED
citys2874
08/5/2024
20:16
It seems pretty lame to blame the Stockmarket for losses incurred by this Company since inception. The CEO does not really have to do anything except give updates and sign off an RNS, the Secretary and Accountants take care of that and in anycase they still have to report and account for what they are doing to existing shareholders and Companies House.
Load of BLX that!

isis
08/5/2024
16:59
They've blown nearly £20m in 4 years with virtually no revenue. In fact each year got much worse, no wonder they're delisting!
isis
08/5/2024
16:45
They've been burning Cash like Bob Marley used to burn Spliff's as far as I can make out!

Financial Highlights

-- Robust balance sheet, debt-free with cash reserves of approximately GBP2.3m at year-end (30 April 2022: GBP9.2m). Cash is forecast to be fully utilised by April 2024.

-- Cash absorbed by operations of GBP7.0m (FY2022: GBP5.4m); Loss for year of GBP5.9m (30 April 2022: GBP4.7m).

-- Basic and diluted loss per share of (0.62p) (30 April 2022: 0.49p loss).
-- Cost savings continued, including closure of London office in April 2022, expected to generate savings of approximately GBP130k p.a.

-- Research costs (excluding salary costs) increased in line with budget to GBP4.3m (30 April 2022: GBP2.9m), of which GBP2.0m relates to OCT461201 and GBP1.9m on OCT130401. A further GBP0.4m was spent on Programmes 3 and 4 mainly relating to the development of CB1/CB2 agonists by Dalriada .

-- Operational costs increased from GBP2.3m to GBP2.7m, including salaries and associated costs of GBP1.4m.

-- Exceptional items of GBP0.1m (30 April 2022: GBP0.3m) relate to share based (non-cash) payment charges. R&D tax credit in the period of GBP1.1m (30 April 2022: GBP0.8m), with tax losses surrendered for the R&D tax credit payment.

isis
08/5/2024
16:27
This Company is wailing about being undervalued and leaving the Markets but issuing a Billion Shares a couple of months ago to raise £640k does not exactly show they were in a good financial position.
isis
08/5/2024
16:19
There must be someone out there that will buy this cheap
revell40
08/5/2024
07:56
Hi toes More people know you idiots
zxie
08/5/2024
06:20
This market is terrible.....we sell our shares due to this rns....they carry on trading make a huge announcement and guess who's bought our shares.....the directors!!! Could be worse it could be Bidstack!
bibdaddy
24/4/2024
15:30
Good to see a lord on the board, and the return of volume.. Chocks away.
paulhopeful
24/4/2024
13:11
there's been blocks of buys recently, MM's keeping this down to fill thee large orders.
This will take off as soon as the order books have been filled.
Great opportunity considering recent placing 0.5p

sep800
24/4/2024
12:33
16.5 million buy trade just gone through and a stack of buying in general today. Let's hope for a leak
bibdaddy
20/4/2024
21:55
Is that the placing shares finished? Double bottom! And a 10,000,000 buy. Think this will start to move now.
paulhopeful
Chat Pages: 39  38  37  36  35  34  33  32  31  30  29  28  Older

Your Recent History

Delayed Upgrade Clock